Biotime-Nasdaq's best kept secret? | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Biotime-Nasdaq's best kept secret?

An SI Board Since May 1996

Posts	SubjectMarks	Bans	Symbol
1432	16	0	BTIM

Emcee: William Nguyen	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
982	Baxter stopping there blood substitute trials should be good news for Hextend s	John L.	-	6/2/1998
981	<offtopic> Baxter suspends blood substitute trials: DEERFIELD, Ill., J	Craig McNeill	-	6/2/1998
980	Do you know if the FDA will announce whether fast track decision on Hextend wil	John L.	-	5/30/1998
979	The reasoning (or lack thereof) of the short position has been no secret. It h	Jim Roof	-	5/29/1998
978	I don't know about the short numbers, but I would sure like to hear some wo	John L.	-	5/28/1998
977	i thought that the short figures for april were due out today. has anyone heard	mesaone	-	5/28/1998
976	Mesaone- A suggestion: Grab a dictionary or, if by chance you have an old cop	Anaxagoras	-	5/26/1998
975	Just a general question, and maybe some advice from those of you who are wiser	Michael Kulikowski	-	5/25/1998
974	i have been watching and listening and participating (sometimes)to stephen'	mesaone	-	5/24/1998
973	<i>I am saying that Hextend cannot be properly criticized by relying on d	Stephen How	-	5/22/1998
972	I am saying that Hextend cannot be properly criticized by relying on data that	Jim Roof	-	5/22/1998
971	<i>As for the desire to market Pentalyte as an Albumin replacement - that	Stephen How	-	5/22/1998
970	<<I have to believe that Abbott is involved because either they weren	Jim Roof	-	5/22/1998
969	Saul, I really can't see much of an advantage for Hextend&reg. I thin	Stephen How	-	5/22/1998
968	Steve, You say, " Abbott will be getting both these products for a cost m	Saul H Rosenthal	-	5/22/1998
967	Jim, Don't forget that Abbott may get a pentastarch in the deal also. (ht	Stephen How	-	5/21/1998
966	If the market for Hextend is only 30M as you say then it seems odd that Abbott	Jim Roof	-	5/21/1998
965	Saul, I think Abbott is getting a good deal here. They will be getting a FDA	Stephen How	-	5/21/1998
964	Steve, Do you really think that your analysis, or that of Asencio, is really m	Saul H Rosenthal	-	5/21/1998
963	<i>How much does it cost to infuse CA? and other electrolytes? If the tot	Stephen How	-	5/21/1998
962	If HES already does "it" then why does the data show clearly that &qu	Jim Roof	-	5/21/1998
961	Jim, Classic. You're the best. <i>your slant seems to me to simply	Stephen How	-	5/21/1998
960	Insiders Buy BTIM! Greenway Partners recently bought a total of 29,000 shar	BulbaMan	-	5/21/1998
959	Steven, My issue is simply that you are a monotone and have had nothing new to	Jim Roof	-	5/21/1998
958	More abstracts from Medline, emphasizing large (> 1.5 L) HES volume replacem	Stephen How	-	5/21/1998

Go to reply# or date (mm/dd/yy):